Researchers from the Johns Hopkins Kimmel Cancer Center have identified key markers in pancreatic cancer progession using a new analysis pipeline. The findings are key to understanding how precancerous lesions in the pancreas progress to pancreatic ductal adenocarcinoma (PDAC), laying a foundation for future early detection of this and other types of pancreatic cancer.
